Wataru Nishie Selected Research

Blister (Bulla)

12/2021	Granzyme B inhibition reduces disease severity in autoimmune blistering diseases.
9/2021	Neonatal Linear IgA Bullous Dermatosis Mediated by Breast Milk-Borne Maternal IgA.
3/2021	A case of anti-BP230 antibody-positive bullous pemphigoid receiving DPP-4 inhibitor.
12/2020	Collagen XVII Processing and Blistering Skin Diseases.
3/2019	Dipeptidyl peptidase IV inhibitor-associated bullous pemphigoid: a recently recognized autoimmune blistering disease with unique clinical, immunological and genetic characteristics.
1/2019	The direct binding of collagen XVII and collagen IV is disrupted by pemphigoid autoantibodies.
1/2018	Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.
12/2017	In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases.
5/2015	Context-Dependent Regulation of Collagen XVII Ectodomain Shedding in Skin.
4/2015	In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wataru Nishie Research Topics

Disease

55	Bullous Pemphigoid (Pemphigoid) 12/2021 - 03/2007
17	Blister (Bulla) 12/2021 - 12/2009
10	Skin Diseases (Skin Disease) 10/2021 - 03/2007
6	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 03/2007
6	Epidermolysis Bullosa Simplex (Epidermolysis Bullosa Herpetiformis Dowling Meara) 12/2017 - 03/2010
4	Pemphigus (Pemphigus Vulgaris) 02/2019 - 03/2012
4	Epidermolysis Bullosa 12/2017 - 03/2010
4	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 07/2014 - 04/2006
3	Linear IgA Bullous Dermatosis 09/2021 - 12/2017
3	Erythema 03/2019 - 03/2014
3	Muscular Dystrophies (Muscular Dystrophy) 04/2011 - 03/2010
2	Rare Diseases (Rare Disease) 09/2021 - 05/2011
2	Dermatitis Herpetiformis (Disease, Duhring's) 07/2021 - 05/2011
2	Type 2 Diabetes Mellitus (MODY) 03/2021 - 01/2019
2	Diabetes Mellitus 01/2019 - 01/2019
2	Multiple Sclerosis 01/2019 - 01/2019
2	Oral Lichen Planus 11/2016 - 05/2003
2	Junctional Epidermolysis Bullosa (Epidermolysis Bullosa Letalis) 09/2009 - 01/2009
1	Bone Fractures (Bone Fracture) 01/2022
1	Hereditary leiomyomatosis and renal cell cancer 01/2022
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Aphthous Stomatitis (Aphthous Ulcer) 10/2021
1	Respiratory Insufficiency (Respiratory Failure) 09/2021
1	Celiac Disease (Celiac Sprue) 07/2021
1	Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis) 07/2021
1	Pruritus (Itching) 03/2021
1	Scabies (Sarcoptic Mange) 07/2020
1	Immune Reconstitution Inflammatory Syndrome 06/2020
1	Hemophilia A (Haemophilia) 06/2020
1	Epidermolysis Bullosa Acquisita (Acquired Epidermolysis Bullosa) 12/2019
1	Parkinson Disease (Parkinson's Disease) 01/2019
1	Alzheimer Disease (Alzheimer's Disease) 01/2019
1	Dementia (Dementias) 01/2019
1	Ichthyosis (Xeroderma) 01/2019
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	X-Linked Syndrome Enteropathy Polyendocrinopathy Immune Dysregulation 12/2018
1	Syringoma 12/2018
1	Burns 01/2018
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Angioedema 12/2017
1	Cheilitis 12/2016
1	Dermatitis 11/2016

Drug/Important Bio-Agent (IBA)

43	AutoantibodiesIBA 01/2022 - 12/2009
28	Collagen Type XVIIIBA 12/2020 - 03/2007
19	Immunoglobulin G (IgG)IBA 07/2021 - 09/2009
13	Dipeptidyl-Peptidase IV InhibitorsIBA 10/2021 - 01/2017
11	EpitopesIBA 10/2021 - 12/2009
6	Proteins (Proteins, Gene)FDA Link 12/2020 - 08/2010
6	AutoantigensIBA 12/2018 - 03/2007
5	AntibodiesIBA 01/2016 - 09/2009
4	Matrix Metalloproteinases (MMPs)IBA 10/2021 - 01/2016
4	AntigensIBA 10/2021 - 02/2010
4	Immunoglobulin A (IgA)IBA 09/2021 - 05/2011
4	PlectinIBA 12/2017 - 03/2010
3	Immunoglobulins (Immunoglobulin)IBA 10/2021 - 03/2010
3	CollagenIBA 01/2019 - 12/2010
3	Immunoglobulin E (IgE)IBA 04/2015 - 05/2011
2	Nonsense Codon (Nonsense Mutation)IBA 01/2022 - 12/2006
2	Granzymes (Granzyme)IBA 12/2021 - 12/2020
2	VildagliptinIBA 03/2021 - 10/2017
2	Pharmaceutical PreparationsIBA 03/2019 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 10/2010
2	Dapsone FDA Link 01/2017 - 03/2012
2	Collagen Type VIIIBA 12/2009 - 04/2006
1	Fumarate Hydratase (Fumarase)IBA 01/2022
1	Serine Proteases (Serine Protease)IBA 12/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 10/2021
1	LinagliptinIBA 10/2021
1	Secretory Immunoglobulin A (SIgA)IBA 09/2021
1	Antihypertensive Agents (Antihypertensives)IBA 05/2021
1	Peptide Hydrolases (Proteases)FDA Link 12/2020
1	Leukocyte Elastase (Neutrophil Elastase)IBA 12/2020
1	Fibrinolysin FDA Link 12/2020
1	laminin gamma 1IBA 11/2019
1	Rituximab (Mabthera)FDA Link 02/2019
1	Carrier Proteins (Binding Protein)IBA 01/2019
1	Rheumatoid FactorIBA 01/2019
1	loricrinIBA 01/2019
1	3- (4- (4- (3- methyl- 1- phenyl- 1H- pyrazol- 5- yl)piperazin- 1- yl)pyrrolidin- 2- ylcarbonyl)thiazolidineIBA 07/2018
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2018
1	HLA-DQB1 antigen (HLA DQB1)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	Angiotensin Receptor AntagonistsIBA 12/2017
1	ImmunosorbentsIBA 11/2017
1	EnzymesIBA 11/2017
1	anagliptinIBA 10/2017
1	Chimeric Antigen ReceptorsIBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 01/2017
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2017
1	Leukotriene B4IBA 01/2017
1	Dimethyl FumarateIBA 01/2017
1	Calcineurin InhibitorsIBA 12/2016
1	Protein Kinase CIBA 12/2016
1	Desmoglein 3IBA 11/2016
1	DesmogleinsIBA 11/2016

Therapy/Procedure

2	Therapeutics 12/2009 - 12/2006
1	Liver Transplantation 12/2018
1	Radiotherapy 01/2018